Per Ljungman, Senior Physician and Hematologist at Karolinska University Hospital, shared an article on LinkedIn:
“Today I’m happy to communicate that the new Recommendations from the 10th European Conference on Infections in Leukemia for management of cytomegalovirus in patients after allogeneic hematopoietic cell transplantation and other T-cell-engaging therapies were published in Lancet Infectious Diseases.”
Recommendations from the 10th European Conference on Infections in Leukaemia for the management of cytomegalovirus in patients after allogeneic haematopoietic cell transplantation and other T-cell-engaging therapies.
Authors: Per Ljungman, et al.
